Filter
683
Text search:
emergency
medicine
specialists
Featured
66
174
Language
Document type
350
109
97
72
32
8
7
5
2
1
Countries
49
31
24
23
21
17
17
16
13
12
12
11
11
11
10
10
10
9
9
9
8
7
6
6
6
6
5
5
5
5
5
5
5
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
259
68
53
47
32
11
2
1
Toolboxes
84
34
34
33
31
25
22
19
19
18
17
17
16
15
14
14
10
9
8
6
5
4
3
3
2
Sixth edition
2007
Rapid Advice Guideline
Establishing trauma referral pathways to provide urgent life-saving assistance for displaced populations and civilians remaining in Ar-Raqqa.
In July 2017, a WHO team comprising an external trauma care specialist and two WHO staff members visited the governorates of Ar-Raqqa and neighbouring Al-Ha
...
NHSP 2017- 2022 (Final draft)
Experience of national TB partnerships
Learning from the Use of Data, Information, and Digital Technologies in the West Africa Ebola Outbreak Response
DHS Comparative Reports No. 41
This research paper uses the Health Resources and services Availability Mapping System (HeRAMS) database to develop two composite indices – one for health centres and one for hospitals – in order to analyse and assess the health facilities’ performance across time and to evaluate the di
...
The State of the World’s Children 2013: Children with Disabilities examines the barriers – from inaccessible buildings to dismissive attitudes, from invisibility in official statistics to vicious discrimination – that deprive children with disabilities of their rights and keep them from partic
...
A community-based approach.
These guidelines focus on manmade rather than natural disasters, but our experiences in India, El Salvador and Pakistan (earthquake interventions), and following the 2004 tsunami, cyclone Nargis in 2008 and the Haiti earthquake in 2010, showed that the principles describ
...
The Global Campaign Against Epilepsy “Out of the Shadows”
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
